Patent details

90869 Product Name: Olanzapine à l'état amorphe (Zyprexa®)

Basic Information

Publication number:
90869
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP913036794
Legal Status:
Lapsed
Application number:
90869
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/96/022/016-018
Marketing Authorization Type:
Marketing Authorization Date:
02/07/2001
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
21/12/2001
First Marketing Authorization date:
02/07/2001
Grant date:
21/02/2002
Activation date:
24/04/2011
Publication date:
21/02/2002
Lapsed date:
Expiration date:
Renunciation date:
04/02/2011
Revocation date:
Annulment date:
Basic SPC Expiration:
24/04/2016
SPC Extension Expiration:
24/04/2016
Rejection date:
Withdrawal date:

Owner

From:
21/12/2001
 
 

Name:
ELI LILLY AND COMPANY LIMITED
Address:
KINGSCLERE ROAD,, BASINGSTOKE. HAMPSHIRE RG21 6XA, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/12/2001
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:
Filing date Document type Number of pages